| 1 |
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4. J Clin Oncol. 2014 Dec 1;32(34):3874-82.
|
| 2 |
2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
|
| 3 |
Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
|
| 4 |
ClinicalTrials.gov (NCT01551043) Allo CART-19 Protocol
|
| 5 |
ClinicalTrials.gov (NCT03191773) A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
|
| 6 |
ClinicalTrials.gov (NCT02851589) Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
|
| 7 |
ClinicalTrials.gov (NCT03389035) Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT
|
| 8 |
Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| 9 |
ClinicalTrials.gov (NCT02819583) CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma
|
| 10 |
ClinicalTrials.gov (NCT01853631) Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
|
| 11 |
ClinicalTrials.gov (NCT03448393) CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
|
| 12 |
Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience.Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019017. doi: 10.4084/MJHID.2019.017. eCollection 2019.
|
| 13 |
Design and synthesis of phosphoryl-substituted diphenylpyrimidines (Pho-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors: Targeted treatment of B lymphoblastic leukemia cell lines.Bioorg Med Chem. 2017 Jan 15;25(2):765-772. doi: 10.1016/j.bmc.2016.11.054. Epub 2016 Nov 29.
|
| 14 |
hBUB1 defects in leukemia and lymphoma cells.Oncogene. 2002 Jul 11;21(30):4673-9. doi: 10.1038/sj.onc.1205585.
|
| 15 |
Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.Clin Cancer Res. 1999 Dec;5(12):4041-7.
|
| 16 |
Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia.Int J Lab Hematol. 2018 Jun;40(3):343-351. doi: 10.1111/ijlh.12795. Epub 2018 Mar 2.
|
| 17 |
Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.Biomed Pharmacother. 2018 Jan;97:1493-1500. doi: 10.1016/j.biopha.2017.11.033. Epub 2017 Nov 20.
|
| 18 |
SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression.Cell Rep. 2018 Apr 24;23(4):1166-1177. doi: 10.1016/j.celrep.2018.03.124.
|
| 19 |
Abnormal expression of CD66a promotes proliferation and inhibits apoptosis of human leukemic B cells in vitro.Leuk Lymphoma. 2015 Jan;56(1):202-10. doi: 10.3109/10428194.2014.913287. Epub 2014 Jun 6.
|
| 20 |
Expression and role of granulocyte macrophage colony-stimulating factor receptor (GM-CSFR) and granulocyte colony-stimulating factor receptor (G-CSFR) on Ph-positive acute B lymphoblastic leukemia.Hematology. 2018 Sep;23(8):439-447. doi: 10.1080/10245332.2018.1426540. Epub 2018 Jan 17.
|
| 21 |
Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.Cancer Med. 2018 Apr;7(4):1297-1316. doi: 10.1002/cam4.1323. Epub 2018 Feb 23.
|
| 22 |
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode.ACS Med Chem Lett. 2019 Sep 19;10(10):1498-1503. doi: 10.1021/acsmedchemlett.9b00400. eCollection 2019 Oct 10.
|
| 23 |
Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.BMC Cancer. 2016 May 26;16:335. doi: 10.1186/s12885-016-2374-2.
|
| 24 |
T cell receptor alpha-chain gene rearrangements in B-precursor leukemia are in contrast to the findings in T cell acute lymphoblastic leukemia. Comparative study of T cell receptor gene rearrangement in childhood leukemia.J Clin Invest. 1987 Dec;80(6):1770-7. doi: 10.1172/JCI113270.
|
| 25 |
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia.Leukemia. 2018 Jan;32(1):49-60. doi: 10.1038/leu.2017.174. Epub 2017 Jun 5.
|
| 26 |
Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia.Leuk Lymphoma. 2013 Feb;54(2):310-4. doi: 10.3109/10428194.2012.710330. Epub 2012 Sep 8.
|
| 27 |
RCH-ACV: a lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8.Cancer Genet Cytogenet. 1986 Jan 15;19(3-4):261-9. doi: 10.1016/0165-4608(86)90055-5.
|
| 28 |
Pre T-cell receptor alpha (pTalpha) expression patterns and functional analysis in human T-cell lymphoblastic leukemia.Cell Oncol. 2010;32(1-2):101-8. doi: 10.3233/CLO-2009-0500.
|
| 29 |
Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.Br J Haematol. 2005 Jul;130(2):233-48. doi: 10.1111/j.1365-2141.2005.05594.x.
|
| 30 |
Frequent deletions at 12q14.3 chromosomal locus in adult acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2005 Jan;42(1):87-94. doi: 10.1002/gcc.20116.
|
| 31 |
Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.Haematologica. 2000 Jul;85(7):711-21.
|
| 32 |
Concurrence of B-lymphoblastic leukemia and myeloproliferative neoplasm with copy neutral loss of heterozygosity at chromosome 1p harboring a MPL W515S mutation.Cancer Genet. 2014 Oct-Dec;207(10-12):489-94. doi: 10.1016/j.cancergen.2014.10.001. Epub 2014 Oct 13.
|
| 33 |
Flow cytometric false myeloperoxidase-positive childhood B-lineage acute lymphoblastic leukemia.Cytometry B Clin Cytom. 2018 May;94(3):477-483. doi: 10.1002/cyto.b.21613. Epub 2018 Jan 17.
|
| 34 |
The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype.Blood. 2003 Dec 15;102(13):4493-8. doi: 10.1182/blood-2002-11-3461. Epub 2003 Jun 19.
|
| 35 |
Transcriptional activation of prostate specific homeobox gene NKX3-1 in subsets of T-cell lymphoblastic leukemia (T-ALL).PLoS One. 2012;7(7):e40747. doi: 10.1371/journal.pone.0040747. Epub 2012 Jul 27.
|
| 36 |
GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia.Cancer Discov. 2019 Dec;9(12):1774-1791. doi: 10.1158/2159-8290.CD-19-0471. Epub 2019 Sep 13.
|
| 37 |
The KOR-SA3544 antigen predominantly expressed on the surface of Philadelphia chromosome-positive acute lymphoblastic leukemia cells is nonspecific cross-reacting antigen-50/90 (CD66c) and invariably expressed in cytoplasm of human leukemia cells.Leukemia. 1999 May;13(5):779-85. doi: 10.1038/sj.leu.2401408.
|
| 38 |
Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14908-13. doi: 10.1073/pnas.1109023108. Epub 2011 Jul 7.
|
| 39 |
SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia Patients.Int J Mol Sci. 2019 Dec 7;20(24):6175. doi: 10.3390/ijms20246175.
|
| 40 |
Impaired telomere regulation mechanism by TRF1 (telomere-binding protein), but not TRF2 expression, in acute leukemia cells.Int J Oncol. 2001 Mar;18(3):593-8. doi: 10.3892/ijo.18.3.593.
|
| 41 |
Expression of DNA repair gene Ku80 in lymphoid neoplasm.Eur J Haematol. 2005 Jun;74(6):481-8. doi: 10.1111/j.1600-0609.2005.00428.x.
|
| 42 |
Deletion of the RNA-binding proteins ZFP36L1 and ZFP36L2 leads to perturbed thymic development and T lymphoblastic leukemia.Nat Immunol. 2010 Aug;11(8):717-24. doi: 10.1038/ni.1901. Epub 2010 Jul 11.
|
| 43 |
Silencer of death domains controls cell death through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemia.PLoS One. 2014 Jul 25;9(7):e103383. doi: 10.1371/journal.pone.0103383. eCollection 2014.
|
| 44 |
Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia.Leuk Res. 2012 Aug;36(8):1009-15. doi: 10.1016/j.leukres.2012.04.018. Epub 2012 May 14.
|
| 45 |
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.Leukemia. 2017 Aug;31(8):1779-1787. doi: 10.1038/leu.2016.371. Epub 2016 Dec 6.
|
| 46 |
Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia.Hematology. 2013 Nov;18(6):315-22. doi: 10.1179/1607845413Y.0000000080. Epub 2013 Feb 20.
|
| 47 |
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography.Sci Adv. 2019 Jul 3;5(7):eaaw5096. doi: 10.1126/sciadv.aaw5096. eCollection 2019 Jul.
|
| 48 |
Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.Asia Pac J Clin Oncol. 2015 Dec;11(4):293-8. doi: 10.1111/ajco.12400. Epub 2015 Aug 12.
|
| 49 |
Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia.Clin Chem Lab Med. 2006;44(5):548-55. doi: 10.1515/CCLM.2006.106.
|
| 50 |
Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNF Treatment.Cancer Res. 2017 Aug 15;77(16):4426-4433. doi: 10.1158/0008-5472.CAN-16-2974. Epub 2017 Jun 23.
|
| 51 |
Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43.Cancers (Basel). 2019 Aug 27;11(9):1253. doi: 10.3390/cancers11091253.
|
| 52 |
Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies.MAbs. 2013 Sep-Oct;5(5):723-35. doi: 10.4161/mabs.25282. Epub 2013 Jun 7.
|
| 53 |
Novel compounds that target lipoprotein lipase and mediate growth arrest in acute lymphoblastic leukemia.Bioorg Med Chem Lett. 2018 Jun 1;28(10):1937-1942. doi: 10.1016/j.bmcl.2018.03.061. Epub 2018 Mar 23.
|
| 54 |
Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.J Cancer Res Clin Oncol. 2014 Jun;140(6):873-81. doi: 10.1007/s00432-014-1595-5. Epub 2014 Feb 2.
|
| 55 |
The role of transcription factor Sp1 in the regulation of gamma-glutamyl hydrolase gene expression by the rs3758149 polymorphism in CEM/C1 cells.Pharmazie. 2019 Nov 1;74(11):671-674. doi: 10.1691/ph.2019.9689.
|
| 56 |
Y-box-binding protein 1 contributes to IL-7-mediated survival signaling in B-cell precursor acute lymphoblastic leukemia.Oncol Lett. 2017 Jan;13(1):497-505. doi: 10.3892/ol.2016.5437. Epub 2016 Nov 28.
|
| 57 |
Identification of mutant alleles of JAK3 in pediatric patients with acute lymphoblastic leukemia.Leuk Lymphoma. 2015 May;56(5):1502-6. doi: 10.3109/10428194.2014.957204. Epub 2015 Jan 21.
|
| 58 |
ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.Haematologica. 2019 Aug;104(8):1608-1616. doi: 10.3324/haematol.2018.207837. Epub 2019 Jan 24.
|
| 59 |
Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.J Biol Chem. 2018 Oct 5;293(40):15359-15369. doi: 10.1074/jbc.RA118.002243. Epub 2018 Aug 20.
|
| 60 |
NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.J Transl Med. 2018 Aug 20;16(1):232. doi: 10.1186/s12967-018-1608-2.
|
| 61 |
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.J Immunol Methods. 2019 Dec;475:112429. doi: 10.1016/j.jim.2018.03.005. Epub 2018 Mar 9.
|
| 62 |
Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.J Hematol Oncol. 2014 Jun 2;7:43. doi: 10.1186/1756-8722-7-43.
|
| 63 |
SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.Cancer Genet. 2018 Oct;226-227:30-35. doi: 10.1016/j.cancergen.2018.05.004. Epub 2018 Jun 8.
|
| 64 |
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells.Cancer Immunol Immunother. 2006 Dec;55(12):1515-23. doi: 10.1007/s00262-006-0165-3. Epub 2006 Apr 19.
|
| 65 |
Characterizing Iranian Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Through Gene Expression Profiling of Common ATP Binding Cassette Transporters Subfamily C.J Pediatr Hematol Oncol. 2020 Jan;42(1):41-45. doi: 10.1097/MPH.0000000000001613.
|
| 66 |
Clinical significance of the ABCB1 and ABCG2 gene expression levels in acute lymphoblastic leukemia.Hematology. 2017 Jun;22(5):286-291. doi: 10.1080/10245332.2016.1265780. Epub 2016 Dec 14.
|
| 67 |
A causal mechanism for childhood acute lymphoblastic leukaemia.Nat Rev Cancer. 2018 Aug;18(8):471-484. doi: 10.1038/s41568-018-0015-6.
|
| 68 |
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL. Clin Cancer Res. 2019 Jul 15;25(14):4493-4503.
|
| 69 |
Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.Cancer Lett. 2016 May 28;375(1):127-132. doi: 10.1016/j.canlet.2016.02.040. Epub 2016 Mar 2.
|
| 70 |
AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia.Mol Cancer Ther. 2011 Mar;10(3):437-47. doi: 10.1158/1535-7163.MCT-10-0777. Epub 2011 Jan 24.
|
| 71 |
Homozygous deletions of cyclin-dependent kinase inhibitor genes, p16(INK4A) and p18, in childhood T cell lineage acute lymphoblastic leukemias.Leukemia. 1996 Feb;10(2):255-60.
|
| 72 |
Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.Nat Commun. 2019 Nov 25;10(1):5348. doi: 10.1038/s41467-019-13069-6.
|
| 73 |
14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a.Am J Hematol. 2010 Aug;85(8):575-8. doi: 10.1002/ajh.21758.
|
| 74 |
Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia.Genes Dev. 2019 Sep 1;33(17-18):1265-1279. doi: 10.1101/gad.327593.119. Epub 2019 Aug 8.
|
| 75 |
Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.Int J Lab Hematol. 2019 Aug;41(4):561-571. doi: 10.1111/ijlh.13052. Epub 2019 May 21.
|
| 76 |
Methylation pattern of calcitonin (CALCA) gene in pediatric acute leukemia.J Pediatr Hematol Oncol. 2011 Oct;33(7):534-42. doi: 10.1097/MPH.0b013e3181f46bc4.
|
| 77 |
Cancer immune therapy for lymphoid malignancies: recent advances.Semin Immunopathol. 2019 Jan;41(1):111-124. doi: 10.1007/s00281-018-0696-7. Epub 2018 Jul 13.
|
| 78 |
Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2012 Mar;51(3):250-6. doi: 10.1002/gcc.20949. Epub 2011 Nov 10.
|
| 79 |
Novel CT domain-encoding splice forms of CTGF/CCN2 are expressed in B-lineage acute lymphoblastic leukaemia.Leuk Res. 2015 Aug;39(8):913-20. doi: 10.1016/j.leukres.2015.05.008. Epub 2015 May 22.
|
| 80 |
Molecular Players in Hematologic Tumor Cell Trafficking.Front Immunol. 2019 Feb 6;10:156. doi: 10.3389/fimmu.2019.00156. eCollection 2019.
|
| 81 |
Selectively increased expression and functions of chemokine receptor CCR9 on CD4+ T cells from patients with T-cell lineage acute lymphocytic leukemia.Cancer Res. 2003 Oct 1;63(19):6469-77.
|
| 82 |
The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines.Invest New Drugs. 2012 Apr;30(2):529-40. doi: 10.1007/s10637-010-9594-0. Epub 2010 Dec 1.
|
| 83 |
Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic Leukemia.Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S19-S24.e1. doi: 10.1016/j.clml.2016.02.032.
|
| 84 |
Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia.Br J Haematol. 2020 Jan;188(2):207-223. doi: 10.1111/bjh.16207. Epub 2019 Sep 30.
|
| 85 |
ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.Genes Chromosomes Cancer. 2017 Aug;56(8):608-616. doi: 10.1002/gcc.22464. Epub 2017 May 5.
|
| 86 |
CD38 antibodies in multiple myeloma: back to the future.Blood. 2018 Jan 4;131(1):13-29. doi: 10.1182/blood-2017-06-740944. Epub 2017 Nov 8.
|
| 87 |
Acute lymphocytic leukemia: correlation of clinical features with immunocytochemical classification.Am J Hematol. 1987 May;25(1):13-27. doi: 10.1002/ajh.2830250103.
|
| 88 |
Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expression.Am J Hematol. 2019 Jan;94(1):93-102. doi: 10.1002/ajh.25337. Epub 2018 Nov 25.
|
| 89 |
Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.Eur J Haematol. 2000 Jan;64(1):3-9. doi: 10.1034/j.1600-0609.2000.80097.x.
|
| 90 |
The CD70/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia.J Immunol. 2009 Jan 1;182(1):718-25. doi: 10.4049/jimmunol.182.1.718.
|
| 91 |
Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.Leukemia. 1996 May;10(5):769-73.
|
| 92 |
Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children.Int Immunopharmacol. 2011 Sep;11(9):1211-9. doi: 10.1016/j.intimp.2011.03.022. Epub 2011 Apr 12.
|
| 93 |
Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family.Br J Haematol. 2011 Oct;155(1):73-83. doi: 10.1111/j.1365-2141.2011.08812.x. Epub 2011 Aug 2.
|
| 94 |
High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.Ann Hematol. 2008 Mar;87(3):205-11. doi: 10.1007/s00277-007-0388-1. Epub 2007 Oct 2.
|
| 95 |
Clinical and laboratory features of adult biphenotypic acute leukemia.Asia Pac J Clin Oncol. 2013 Jun;9(2):146-54. doi: 10.1111/j.1743-7563.2012.01571.x. Epub 2012 Jul 9.
|
| 96 |
Properdin factor B and acute lymphocytic leukemia (ALL).Cancer. 1982 Dec 1;50(11):2369-71. doi: 10.1002/1097-0142(19821201)50:11<2369::aid-cncr2820501123>3.0.co;2-s.
|
| 97 |
Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.Genome Res. 2017 Feb;27(2):185-195. doi: 10.1101/gr.209163.116. Epub 2016 Nov 30.
|
| 98 |
C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.Cancer Res. 2004 Nov 15;64(22):8443-50. doi: 10.1158/0008-5472.CAN-04-1659.
|
| 99 |
microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling.Yonsei Med J. 2019 Oct;60(10):924-934. doi: 10.3349/ymj.2019.60.10.924.
|
| 100 |
CBP Modulates Sensitivity to Dasatinib in Pre-BCR(+) Acute Lymphoblastic Leukemia.Cancer Res. 2018 Nov 15;78(22):6497-6508. doi: 10.1158/0008-5472.CAN-18-1703. Epub 2018 Sep 27.
|
| 101 |
CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.J Clin Oncol. 2008 Jun 20;26(18):3031-7. doi: 10.1200/JCO.2007.14.6399.
|
| 102 |
GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2019 Sep;58(9):619-626. doi: 10.1002/gcc.22748. Epub 2019 Apr 3.
|
| 103 |
NF-kappa B mediated up-regulation of CCCTC-binding factor in pediatric acute lymphoblastic leukemia.Mol Cancer. 2014 Jan 7;13:5. doi: 10.1186/1476-4598-13-5.
|
| 104 |
Ghrelin induces autophagy and CXCR4 expression via the SIRT1/AMPK axis in lymphoblastic leukemia cell lines.Cell Signal. 2020 Feb;66:109492. doi: 10.1016/j.cellsig.2019.109492. Epub 2019 Dec 3.
|
| 105 |
The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.Haematologica. 2007 Mar;92(3):308-14. doi: 10.3324/haematol.10752.
|
| 106 |
The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia.J Oncol Pharm Pract. 2016 Feb;22(1):76-81. doi: 10.1177/1078155214553143. Epub 2014 Oct 10.
|
| 107 |
Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.Genet Test Mol Biomarkers. 2017 Oct;21(10):592-599. doi: 10.1089/gtmb.2017.0084. Epub 2017 Aug 2.
|
| 108 |
Folate pathway genetic polymorphisms modulate methotrexate-induced toxicity in childhood acute lymphoblastic leukemia.Cancer Chemother Pharmacol. 2019 Apr;83(4):755-762. doi: 10.1007/s00280-019-03776-8. Epub 2019 Jan 25.
|
| 109 |
miR-187-5p Regulates Cell Growth and Apoptosis in Acute Lymphoblastic Leukemia via DKK2.Oncol Res. 2016;24(2):89-97. doi: 10.3727/096504016X14597766487753.
|
| 110 |
PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease.Leuk Res. 2002 Apr;26(4):335-43. doi: 10.1016/s0145-2126(01)00130-8.
|
| 111 |
Rapid Capture Next-Generation Sequencing in Clinical Diagnostics of Kinase Pathway Aberrations in B-Cell Precursor ALL.Pediatr Blood Cancer. 2016 Jul;63(7):1283-6. doi: 10.1002/pbc.25975. Epub 2016 Mar 23.
|
| 112 |
A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia.Blood Cells Mol Dis. 2005 Jan-Feb;34(1):1-5. doi: 10.1016/j.bcmd.2004.08.025.
|
| 113 |
A blood pact: the significance and implications of eIF4E on lymphocytic leukemia.Physiol Res. 2018 Jul 17;67(3):363-382. doi: 10.33549/physiolres.933696. Epub 2018 Mar 12.
|
| 114 |
N1-guanyl-1,7-diaminoheptane enhances the chemosensitivity of acute lymphoblastic leukemia cells to vincristine through inhibition of eif5a-2 activation.Anticancer Drugs. 2017 Nov;28(10):1097-1105. doi: 10.1097/CAD.0000000000000550.
|
| 115 |
EP300-ZNF384 fusion gene product up-regulates GATA3 gene expression and induces hematopoietic stem cell gene expression signature in B-cell precursor acute lymphoblastic leukemia cells.Int J Hematol. 2017 Aug;106(2):269-281. doi: 10.1007/s12185-017-2220-6. Epub 2017 Apr 4.
|
| 116 |
Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.Blood. 2010 Mar 25;115(12):2412-9. doi: 10.1182/blood-2009-05-222208. Epub 2010 Jan 8.
|
| 117 |
GATA2 regulates the erythropoietin receptor in t(12;21) ALL.Oncotarget. 2017 Aug 2;8(39):66061-66074. doi: 10.18632/oncotarget.19792. eCollection 2017 Sep 12.
|
| 118 |
Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.Cell Rep. 2016 Mar 1;14(8):1953-65. doi: 10.1016/j.celrep.2016.01.064. Epub 2016 Feb 18.
|
| 119 |
Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation.Pediatr Blood Cancer. 2018 May;65(5):e26938. doi: 10.1002/pbc.26938. Epub 2018 Jan 15.
|
| 120 |
Cardiotoxicity evaluation in pediatric patients with acute lymphoblastic leukemia - results of prospective study.Med Ultrason. 2019 Nov 24;21(4):449-455. doi: 10.11152/mu-2012.
|
| 121 |
Case of acute lymphoblastic leukemia presenting with t(14;18)/BCL2, t(8;14)/cMYC, and t(1;2)/FCGR2B.Am J Hematol. 2003 Oct;74(2):112-8. doi: 10.1002/ajh.10393.
|
| 122 |
Altered conjugate formation and altered apoptosis of multidrug-resistant human leukemia cell line affects susceptibility to killing by activated natural killer (NK) cells.Int J Cancer. 2004 Jan 1;108(1):78-85. doi: 10.1002/ijc.11555.
|
| 123 |
Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.J Leukoc Biol. 2009 Mar;85(3):563-73. doi: 10.1189/jlb.0808469. Epub 2009 Jan 16.
|
| 124 |
FHIT Gene Expression in Acute Lymphoblastic Leukemia and its Clinical Significance.Asian Pac J Cancer Prev. 2015;16(18):8197-201. doi: 10.7314/apjcp.2015.16.18.8197.
|
| 125 |
Alternative splicing of Ikaros regulates the FUT4/Le(X)-51 integrin-FAK axis in acute lymphoblastic leukemia.Biochem Biophys Res Commun. 2019 Feb 26;510(1):128-134. doi: 10.1016/j.bbrc.2019.01.064. Epub 2019 Jan 22.
|
| 126 |
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis.Blood. 2004 Sep 1;104(5):1435-41. doi: 10.1182/blood-2003-12-4306. Epub 2004 May 13.
|
| 127 |
Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.Leukemia. 2019 Jan;33(1):230-239. doi: 10.1038/s41375-018-0170-5. Epub 2018 Jun 15.
|
| 128 |
Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.Oncotarget. 2016 Oct 4;7(40):65923-65936. doi: 10.18632/oncotarget.11688.
|
| 129 |
A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene.Cancer Res. 2004 Jun 15;64(12):4089-98. doi: 10.1158/0008-5472.CAN-03-1871.
|
| 130 |
Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3.Leukemia. 1991 Apr;5(4):322-31.
|
| 131 |
Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia.Br J Haematol. 2010 Sep;150(6):665-73. doi: 10.1111/j.1365-2141.2010.08301.x.
|
| 132 |
Persistent rubella infection after erroneous vaccination in an immunocompromised patient with acute lymphoblastic leukemia in remission.J Med Virol. 1995 Dec;47(4):442-4. doi: 10.1002/jmv.1890470425.
|
| 133 |
Glutathione-S-transferase polymorphism and acute lymphoblastic leukemia (ALL) in north Indian children: a case-control study and meta-analysis.J Hum Genet. 2014 Sep;59(9):529-35. doi: 10.1038/jhg.2014.66. Epub 2014 Aug 7.
|
| 134 |
Duplicated regions of AF-4 intron 4 at t(4;11) translocation breakpoints.Mol Diagn. 1999 Dec;4(4):269-83. doi: 10.1016/s1084-8592(99)80002-2.
|
| 135 |
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.Haematologica. 2019 Apr;104(4):749-755. doi: 10.3324/haematol.2018.205252. Epub 2018 Oct 25.
|
| 136 |
Deleterious and Oncogenic Mutations in the IL7RA.Cancers (Basel). 2019 Dec 5;11(12):1952. doi: 10.3390/cancers11121952.
|
| 137 |
G9a Correlates with VLA-4 Integrin and Influences the Migration of Childhood Acute Lymphoblastic Leukemia Cells.Cancers (Basel). 2018 Sep 12;10(9):325. doi: 10.3390/cancers10090325.
|
| 138 |
Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.J Hematol Oncol. 2017 Feb 28;10(1):61. doi: 10.1186/s13045-017-0431-1.
|
| 139 |
shRNA screening identifies JMJD1C as being required for leukemia maintenance.Blood. 2014 Mar 20;123(12):1870-82. doi: 10.1182/blood-2013-08-522094. Epub 2014 Feb 5.
|
| 140 |
Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia.J Pediatr Hematol Oncol. 2017 Nov;39(8):585-588. doi: 10.1097/MPH.0000000000000921.
|
| 141 |
Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.Pharmacogenet Genomics. 2016 Feb;26(2):100-2. doi: 10.1097/FPC.0000000000000191.
|
| 142 |
Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia.Haematologica. 2020 Jan;105(1):170-181. doi: 10.3324/haematol.2018.199364. Epub 2019 May 9.
|
| 143 |
Isocitrate dehydrogenase mutation hot spots in acute lymphoblastic leukemia and oral cancer.Kaohsiung J Med Sci. 2012 Mar;28(3):138-44. doi: 10.1016/j.kjms.2011.10.023. Epub 2012 Jan 20.
|
| 144 |
Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.Haematologica. 2003 Jun;88(6):654-8.
|
| 145 |
Polymorphisms in innate immunity genes and risk of childhood leukemia.Hum Immunol. 2010 Jul;71(7):727-30. doi: 10.1016/j.humimm.2010.04.004. Epub 2010 May 16.
|
| 146 |
Acute lymphoblastic leukemia in the context of RASopathies.Eur J Med Genet. 2016 Mar;59(3):173-8. doi: 10.1016/j.ejmg.2016.01.003. Epub 2016 Feb 5.
|
| 147 |
Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells.BMC Cancer. 2015 Apr 7;15:226. doi: 10.1186/s12885-015-1282-1.
|
| 148 |
Targeting Mcl-1 and other Bcl-2 family member proteins in cancer therapy.Pharmacol Ther. 2019 Mar;195:13-20. doi: 10.1016/j.pharmthera.2018.10.009. Epub 2018 Oct 19.
|
| 149 |
Wnt/catenin inhibition reverses multidrug resistance in pediatric acute lymphoblastic leukemia.Oncol Rep. 2019 Feb;41(2):1387-1394. doi: 10.3892/or.2018.6902. Epub 2018 Dec 4.
|
| 150 |
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.JCI Insight. 2018 Nov 2;3(21):e97941. doi: 10.1172/jci.insight.97941.
|
| 151 |
PKC and PKM are overexpressed in TCF3-rearranged paediatric acute lymphoblastic leukaemia and are associated with increased thiopurine sensitivity.Leukemia. 2015 Feb;29(2):304-11. doi: 10.1038/leu.2014.210. Epub 2014 Jul 3.
|
| 152 |
Focused screening of a panel of cancer-related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia.Pediatr Blood Cancer. 2014 Aug;61(8):1411-5. doi: 10.1002/pbc.25011. Epub 2014 Mar 6.
|
| 153 |
Lack of expression of MTAP in uncommon T-cell lymphomas.Clin Lymphoma Myeloma Leuk. 2012 Oct;12(5):306-9. doi: 10.1016/j.clml.2012.07.001.
|
| 154 |
Thymidylate synthase and methionine synthase polymorphisms are not associated with susceptibility to childhood acute lymphoblastic leukemia in Kurdish population from Western Iran.Mol Biol Rep. 2012 Mar;39(3):2195-200. doi: 10.1007/s11033-011-0968-y. Epub 2011 Jun 5.
|
| 155 |
Targeting CDK6 and BCL2 Exploits the "MYB Addiction" of Ph(+) Acute Lymphoblastic Leukemia.Cancer Res. 2018 Feb 15;78(4):1097-1109. doi: 10.1158/0008-5472.CAN-17-2644. Epub 2017 Dec 12.
|
| 156 |
Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.Asian Pac J Cancer Prev. 2014;15(22):9961-6. doi: 10.7314/apjcp.2014.15.22.9961.
|
| 157 |
Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults.Hematology. 2017 Mar;22(2):81-87. doi: 10.1080/10245332.2016.1238183. Epub 2016 Oct 13.
|
| 158 |
Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia.Oncotarget. 2017 Dec 31;9(5):5529-5544. doi: 10.18632/oncotarget.23797. eCollection 2018 Jan 19.
|
| 159 |
Role of neuropilin-1 and its expression in Egyptian acute myeloid and acute lymphoid leukemia patients.Leuk Res. 2012 Feb;36(2):169-73. doi: 10.1016/j.leukres.2011.08.017. Epub 2011 Oct 5.
|
| 160 |
Serum nm23-H1 protein as a prognostic factor in hematological malignancies.Leuk Lymphoma. 2002 Apr;43(4):859-67. doi: 10.1080/10428190290017006.
|
| 161 |
Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression.J Immunol Res. 2019 Jun 27;2019:5601396. doi: 10.1155/2019/5601396. eCollection 2019.
|
| 162 |
Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.Ann Hematol. 2004 Aug;83(8):527-32. doi: 10.1007/s00277-004-0843-1. Epub 2004 Feb 5.
|
| 163 |
The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated-recombinant arginase I BCT-100.Int J Cancer. 2018 Apr 1;142(7):1490-1502. doi: 10.1002/ijc.31170. Epub 2017 Dec 26.
|
| 164 |
Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression.Clin Epigenetics. 2018 Jun 19;10:83. doi: 10.1186/s13148-018-0516-x. eCollection 2018.
|
| 165 |
Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.Leukemia. 2017 Jul;31(7):1491-1501. doi: 10.1038/leu.2016.365. Epub 2016 Nov 30.
|
| 166 |
Pneumatosis cystoides intestinalis with abdominal free air in a 2-year-old girl after allogeneic bone marrow transplantation.Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):81-4. doi: 10.3109/08880019809009512.
|
| 167 |
Down-regulation of cyclic nucleotide phosphodiesterase PDE1A is the key event of p73 and UHRF1 deregulation in thymoquinone-induced acute lymphoblastic leukemia cell apoptosis.Cell Signal. 2011 Jan;23(1):152-60. doi: 10.1016/j.cellsig.2010.08.015. Epub 2010 Aug 31.
|
| 168 |
Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL.Blood Adv. 2018 Oct 9;2(19):2554-2567. doi: 10.1182/bloodadvances.2018020693.
|
| 169 |
Acute lymphoblastic leukemia in a child with the CHIME neuroectodermal dysplasia syndrome.Am J Med Genet. 1997 Oct 3;72(1):24-9.
|
| 170 |
KMT2A rearranged acute lymphoblastic leukaemia: Unravelling the genomic complexity and heterogeneity of this high-risk disease.Cancer Lett. 2020 Jan 28;469:410-418. doi: 10.1016/j.canlet.2019.11.005. Epub 2019 Nov 6.
|
| 171 |
Expression of PIM-2 and NF-B genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.Postepy Hig Med Dosw (Online). 2013 Jun 7;67:553-9. doi: 10.5604/17322693.1052449.
|
| 172 |
Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia.Nanoscale. 2019 Dec 21;11(47):23000-23012. doi: 10.1039/c9nr07391d. Epub 2019 Nov 26.
|
| 173 |
Abnormally high expression of POLD1, MCM2, and PLK4 promotes relapse of acute lymphoblastic leukemia.Medicine (Baltimore). 2018 May;97(20):e10734. doi: 10.1097/MD.0000000000010734.
|
| 174 |
Enzyme analysis of lymphoproliferative diseases: a useful addition to cell surface phenotyping.Blood. 1983 Sep;62(3):669-76.
|
| 175 |
Genome-Wide Study Links PNPLA3 Variant With Elevated Hepatic Transaminase After Acute Lymphoblastic Leukemia Therapy.Clin Pharmacol Ther. 2017 Jul;102(1):131-140. doi: 10.1002/cpt.629. Epub 2017 Apr 4.
|
| 176 |
Cytogenetic and molecular study of the PRDX4 gene in a t(X;18)(p22;q23): a cautionary tale.Cancer Genet Cytogenet. 2007 Jul 15;176(2):131-6. doi: 10.1016/j.cancergencyto.2007.03.010.
|
| 177 |
Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia.Blood. 2019 Oct 10;134(15):1257-1268. doi: 10.1182/blood.2019002457.
|
| 178 |
Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report.Haematologica. 2019 Mar;104(3):556-563. doi: 10.3324/haematol.2018.199356. Epub 2018 Nov 22.
|
| 179 |
Aptamer-facilitated mass cytometry.Anal Bioanal Chem. 2018 May;410(13):3047-3051. doi: 10.1007/s00216-018-1011-0. Epub 2018 Mar 20.
|
| 180 |
Side scatter versus CD45 flow cytometric plot can distinguish acute leukaemia subtypes.Indian J Med Res. 2016 May;143(Supplement):S17-S22. doi: 10.4103/0971-5916.191743.
|
| 181 |
Induction of murine leukemia and lymphoma by dominant negative retinoic acid receptor alpha.Mol Carcinog. 2005 Dec;44(4):252-61. doi: 10.1002/mc.20144.
|
| 182 |
Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.Oncogene. 2019 Apr;38(17):3288-3300. doi: 10.1038/s41388-018-0670-9. Epub 2019 Jan 10.
|
| 183 |
Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.Exp Mol Pathol. 2012 Feb;92(1):44-9. doi: 10.1016/j.yexmp.2011.09.004. Epub 2011 Oct 19.
|
| 184 |
Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood.Leukemia. 1996 Jul;10(7):1104-10.
|
| 185 |
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL.Bone Marrow Transplant. 2019 Nov;54(11):1847-1858. doi: 10.1038/s41409-019-0543-z. Epub 2019 May 14.
|
| 186 |
SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24.Cancer Res. 2002 Jan 15;62(2):333-7.
|
| 187 |
MiR-595 Suppresses the Cellular Uptake and Cytotoxic Effects of Methotrexate by Targeting SLC19A1 in CEM/C1 Cells.Basic Clin Pharmacol Toxicol. 2018 Jul;123(1):8-13. doi: 10.1111/bcpt.12966. Epub 2018 Feb 22.
|
| 188 |
Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.Cancer Chemother Pharmacol. 1989;24(4):203-10. doi: 10.1007/BF00257619.
|
| 189 |
A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to BAcute Lymphoblastic Leukemia-Associated ETV6-RUNX1.Dev Cell. 2018 Feb 5;44(3):362-377.e7. doi: 10.1016/j.devcel.2017.12.005. Epub 2017 Dec 28.
|
| 190 |
Association between a microRNA binding site polymorphism in SLCO1A2 and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia.Leuk Res. 2018 Feb;65:61-66. doi: 10.1016/j.leukres.2018.01.004. Epub 2018 Jan 2.
|
| 191 |
Overexpression of SET and MYND domain-containing protein 2 (SMYD2) is associated with poor prognosis in pediatric B lineage acute lymphoblastic leukemia.Leuk Lymphoma. 2020 Feb;61(2):437-444. doi: 10.1080/10428194.2019.1675875. Epub 2019 Oct 15.
|
| 192 |
Long non-coding RNA SNHG16 has Tumor suppressing effect in acute lymphoblastic leukemia by inverse interaction on hsa-miR-124-3p.IUBMB Life. 2019 Jan;71(1):134-142. doi: 10.1002/iub.1947. Epub 2018 Oct 31.
|
| 193 |
Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression.Cancer Res. 2014 May 15;74(10):2803-15. doi: 10.1158/0008-5472.CAN-13-2732. Epub 2014 Mar 31.
|
| 194 |
Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias.J Clin Oncol. 2007 Apr 10;25(11):1341-9. doi: 10.1200/JCO.2006.09.3534. Epub 2007 Feb 20.
|
| 195 |
Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.J Biol Chem. 2014 Jul 25;289(30):20502-15. doi: 10.1074/jbc.M114.569889.
|
| 196 |
Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics.Blood. 2019 Feb 14;133(7):724-729. doi: 10.1182/blood-2018-07-862946. Epub 2018 Dec 3.
|
| 197 |
IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization.Cancer Genet Cytogenet. 2004 Jul 15;152(2):141-5. doi: 10.1016/j.cancergencyto.2003.11.008.
|
| 198 |
Expression of thrombopoietin receptor and its functional role in human B-precursor leukemia cells with 11q23 translocation or Philadelphia chromosome.Leukemia. 2000 Sep;14(9):1598-605. doi: 10.1038/sj.leu.2401893.
|
| 199 |
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.Sci Transl Med. 2019 Sep 25;11(511):eaaw9414. doi: 10.1126/scitranslmed.aaw9414.
|
| 200 |
Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated with BCR-ABL Positivity.Neoplasia. 2018 Nov;20(11):1150-1160. doi: 10.1016/j.neo.2018.09.005. Epub 2018 Oct 6.
|
| 201 |
Treatment of acute lymphoblastic leukaemia with the second generation of CD19 CAR-T containing either CD28 or 4-1BB.Br J Haematol. 2018 May;181(3):360-371. doi: 10.1111/bjh.15195. Epub 2018 Apr 10.
|
| 202 |
Novel cryptic chromosomal rearrangements in childhood acute lymphoblastic leukemia detected by multiple color fluorescent in situ hybridization.Haematologica. 2005 Sep;90(9):1179-85.
|
| 203 |
Progenitor B-1 B-cell acute lymphoblastic leukemia is associated with collaborative mutations in 3 critical pathways.Blood Adv. 2017 Sep 8;1(20):1749-1759. doi: 10.1182/bloodadvances.2017009837. eCollection 2017 Sep 12.
|
| 204 |
Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).Blood. 2015 Jan 29;125(5):820-30. doi: 10.1182/blood-2014-06-583062. Epub 2014 Nov 26.
|
| 205 |
A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia.Haematologica. 2005 Jul;90(7):890-8.
|
| 206 |
Genome-Wide Association Study of Susceptibility Loci for T-Cell Acute Lymphoblastic Leukemia in Children.J Natl Cancer Inst. 2019 Dec 1;111(12):1350-1357. doi: 10.1093/jnci/djz043.
|
| 207 |
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.Cancers (Basel). 2019 Oct 25;11(11):1654. doi: 10.3390/cancers11111654.
|
| 208 |
Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation.BMC Cancer. 2012 Feb 7;12:60. doi: 10.1186/1471-2407-12-60.
|
| 209 |
Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia.Integr Biol (Camb). 2016 Jul 11;8(7):761-74. doi: 10.1039/c6ib00040a. Epub 2016 Jun 17.
|
| 210 |
The role of ZAP70 kinase in acute lymphoblastic leukemia infiltration into the central nervous system.Haematologica. 2017 Feb;102(2):346-355. doi: 10.3324/haematol.2016.147744. Epub 2016 Sep 29.
|
| 211 |
Expression of the MDR1 and MDR3 gene products in acute and chronic leukemias.Leuk Res. 1997 Apr;21(4):313-9. doi: 10.1016/s0145-2126(96)00130-0.
|
| 212 |
mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.Cancer Biol Ther. 2014 Jan;15(1):35-41. doi: 10.4161/cbt.26603. Epub 2013 Oct 21.
|
| 213 |
ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia.Cancer Chemother Pharmacol. 2017 Jul;80(1):109-117. doi: 10.1007/s00280-017-3340-7. Epub 2017 May 26.
|
| 214 |
The rapidly evolving state of gene therapy.FASEB J. 2018 Apr;32(4):1733-1740. doi: 10.1096/fj.201700982R.
|
| 215 |
Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia.Int J Cancer. 2008 Oct 15;123(8):1824-31. doi: 10.1002/ijc.23749.
|
| 216 |
Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia.Anticancer Res. 2019 Oct;39(10):5531-5539. doi: 10.21873/anticanres.13746.
|
| 217 |
A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment.Pharmacogenomics J. 2017 Mar;17(2):180-185. doi: 10.1038/tpj.2015.92. Epub 2016 Feb 9.
|
| 218 |
A distinguished cancer-screening package containing a DNA sensor and an aptasensor for early and certain detection of acute lymphoblastic leukemia.Clin Chim Acta. 2019 Oct;497:41-47. doi: 10.1016/j.cca.2019.07.009. Epub 2019 Jul 8.
|
| 219 |
Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic Target.Front Immunol. 2018 Jan 25;8:1975. doi: 10.3389/fimmu.2017.01975. eCollection 2017.
|
| 220 |
3D culture enhances chemoresistance of ALL Jurkat cell line by increasing DDR1 expression.Exp Ther Med. 2019 Mar;17(3):1593-1600. doi: 10.3892/etm.2019.7153. Epub 2019 Jan 4.
|
| 221 |
Targeting High Dynamin-2 (DNM2) Expression by Restoring Ikaros Function in Acute Lymphoblastic Leukemia.Sci Rep. 2016 Nov 25;6:38004. doi: 10.1038/srep38004.
|
| 222 |
Letter regarding Zhao et al. entitled " DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia".Tumour Biol. 2017 Jun;39(6):1010428317701629. doi: 10.1177/1010428317701629.
|
| 223 |
Physcion blocks cell cycle and induces apoptosis in human B cell precursor acute lymphoblastic leukemia cells by downregulating HOXA5.Biomed Pharmacother. 2017 Oct;94:850-857. doi: 10.1016/j.biopha.2017.07.149. Epub 2017 Aug 10.
|
| 224 |
Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment.J Pediatr Hematol Oncol. 2019 Oct;41(7):e481-e483. doi: 10.1097/MPH.0000000000001267.
|
| 225 |
IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells.Cancer Lett. 2019 Aug 1;456:59-68. doi: 10.1016/j.canlet.2019.04.030. Epub 2019 Apr 28.
|
| 226 |
Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.J Clin Oncol. 2013 Oct 20;31(30):3782-90. doi: 10.1200/JCO.2012.47.4007. Epub 2013 Sep 16.
|
| 227 |
Suppression of HSP70 inhibits the development of acute lymphoblastic leukemia via TAK1/Egr-1.Biomed Pharmacother. 2019 Nov;119:109399. doi: 10.1016/j.biopha.2019.109399. Epub 2019 Sep 12.
|
| 228 |
Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance.Oncotarget. 2017 Dec 13;9(3):3549-3561. doi: 10.18632/oncotarget.23186. eCollection 2018 Jan 9.
|
| 229 |
Antithrombin III as the Indicator of L-Asparaginase Activity in Children Treated for Acute Lymphoblastic Leukemia.J Pediatr Hematol Oncol. 2017 Mar;39(2):114-120. doi: 10.1097/MPH.0000000000000739.
|
| 230 |
The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia.Clin Cancer Res. 2017 May 15;23(10):2528-2541. doi: 10.1158/1078-0432.CCR-16-1580. Epub 2016 Oct 25.
|
| 231 |
AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations.Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10398-403. doi: 10.1073/pnas.171321298.
|
| 232 |
Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.Gene. 2019 Apr 15;692:35-43. doi: 10.1016/j.gene.2019.01.003. Epub 2019 Jan 11.
|
| 233 |
Expression of ABCB5 gene in hematological malignances and its significance.Leuk Lymphoma. 2012 Jun;53(6):1211-5. doi: 10.3109/10428194.2011.637214. Epub 2011 Dec 7.
|
| 234 |
Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.BMC Cancer. 2018 Jul 3;18(1):704. doi: 10.1186/s12885-018-4629-6.
|
| 235 |
Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2013 Feb;52(2):202-13. doi: 10.1002/gcc.22021. Epub 2012 Oct 18.
|
| 236 |
Improving risk stratification of patients with childhood acute lymphoblastic leukemia: Glutathione-S-Transferases polymorphisms are associated with increased risk of relapse.Oncotarget. 2017 Jan 3;8(1):110-117. doi: 10.18632/oncotarget.8606.
|
| 237 |
High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia.Environ Mol Mutagen. 2012 Oct;53(8):619-30. doi: 10.1002/em.21723. Epub 2012 Aug 29.
|
| 238 |
Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia.Br J Haematol. 2010 Jan;148(1):3-14. doi: 10.1111/j.1365-2141.2009.07898.x. Epub 2009 Sep 22.
|
| 239 |
Absence of SCL mutations in myeloid malignancies.Br J Haematol. 2003 Feb;120(3):482-3. doi: 10.1046/j.1365-2141.2003.04122.x.
|
| 240 |
Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia.Oncol Rep. 2019 Jun;41(6):3488-3498. doi: 10.3892/or.2019.7114. Epub 2019 Apr 12.
|
| 241 |
Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome.Rev Environ Health. 2001 Jul-Sep;16(4):263-79. doi: 10.1515/reveh.2001.16.4.263.
|
| 242 |
Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation.Leukemia. 2010 Oct;24(10):1742-50. doi: 10.1038/leu.2010.174. Epub 2010 Aug 12.
|
| 243 |
Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia.Cancer Chemother Pharmacol. 2014 Aug;74(2):283-9. doi: 10.1007/s00280-014-2507-8. Epub 2014 Jun 8.
|
| 244 |
Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.Mol Cancer Ther. 2019 Sep;18(9):1587-1592. doi: 10.1158/1535-7163.MCT-18-1329. Epub 2019 Jun 17.
|
| 245 |
Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia.Cancer Res. 2004 Jul 1;64(13):4464-71. doi: 10.1158/0008-5472.CAN-03-3940.
|
| 246 |
Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3.Hum Mol Genet. 2007 Sep 15;16(18):2215-25. doi: 10.1093/hmg/ddm173. Epub 2007 Jul 5.
|
| 247 |
Multidrug resistance in acute leukemia: a comparison of different diagnostic methods.Leukemia. 1997 Jul;11(7):1067-72. doi: 10.1038/sj.leu.2400691.
|
| 248 |
LAF-4 is aberrantly expressed in human breast cancer.Int J Cancer. 2005 Jul 1;115(4):568-74. doi: 10.1002/ijc.20881.
|
| 249 |
Resistance to farnesyltransferase inhibitors in Bcr/Abl-positive lymphoblastic leukemia by increased expression of a novel ABC transporter homolog ATP11a.Blood. 2005 Aug 15;106(4):1355-61. doi: 10.1182/blood-2004-09-3655. Epub 2005 Apr 28.
|
| 250 |
Deregulation of polycomb repressor complex 1 modifier AUTS2 in T-cell leukemia.Oncotarget. 2016 Jul 19;7(29):45398-45413. doi: 10.18632/oncotarget.9982.
|
| 251 |
MEF2D-BCL9 Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents.J Clin Oncol. 2016 Oct 1;34(28):3451-9. doi: 10.1200/JCO.2016.66.5547. Epub 2016 Aug 9.
|
| 252 |
The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.Haematologica. 2013 Nov;98(11):1711-7. doi: 10.3324/haematol.2013.086082. Epub 2013 Jul 5.
|
| 253 |
Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage.Arch Pathol Lab Med. 2003 Mar;127(3):356-9. doi: 10.5858/2003-127-0356-BALWCO.
|
| 254 |
ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells.Int J Cancer. 1999 Jul 2;82(1):98-104. doi: 10.1002/(sici)1097-0215(19990702)82:1<98::aid-ijc17>3.0.co;2-a.
|
| 255 |
Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria.J Biol Chem. 2008 Jan 18;283(3):1563-1571. doi: 10.1074/jbc.M707997200. Epub 2007 Nov 13.
|
| 256 |
IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia.Transl Oncol. 2019 May;12(5):726-732. doi: 10.1016/j.tranon.2019.02.002. Epub 2019 Mar 13.
|
| 257 |
Epigenetic inactivation of the CIP/KIP cell-cycle control pathway in acute leukemias.Am J Hematol. 2005 Dec;80(4):282-7. doi: 10.1002/ajh.20503.
|
| 258 |
STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients.Blood. 1996 Mar 1;87(5):1692-7.
|
| 259 |
Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia.Cancer Cell. 2018 Dec 10;34(6):906-921.e8. doi: 10.1016/j.ccell.2018.11.002.
|
| 260 |
Expression of DHX32 in lymphoid tissues.Exp Mol Pathol. 2005 Dec;79(3):219-23. doi: 10.1016/j.yexmp.2005.07.002. Epub 2005 Sep 21.
|
| 261 |
Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.Leuk Res. 2015 Dec;39(12):1455-61. doi: 10.1016/j.leukres.2015.10.006. Epub 2015 Oct 20.
|
| 262 |
Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.Leuk Res. 2000 Nov;24(11):965-70. doi: 10.1016/s0145-2126(00)00065-5.
|
| 263 |
STIP Regulates ERK1/2 Signaling Pathway Involved in Interaction with PP1 in Lymphoblastic Leukemia.Curr Mol Med. 2016;16(8):767-775. doi: 10.2174/1566524016666161018154401.
|
| 264 |
Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.Blood. 2015 Jul 2;126(1):69-75. doi: 10.1182/blood-2015-02-628800. Epub 2015 May 18.
|
| 265 |
GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.Am J Clin Pathol. 2017 Apr 1;147(4):420-426. doi: 10.1093/ajcp/aqx018.
|
| 266 |
BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.Am J Clin Pathol. 2015 Apr;143(4):547-57. doi: 10.1309/AJCPO4U4VYAAOTEL.
|
| 267 |
Philadelphia chromosome positive chronic myelogenous leukemia developing in a patient with acute lymphoblastic leukemia.Cancer. 1979 May;43(5):1782-7. doi: 10.1002/1097-0142(197905)43:5<1782::aid-cncr2820430531>3.0.co;2-j.
|
| 268 |
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia.Cancer. 2013 Oct 1;119(19):3555-62. doi: 10.1002/cncr.28256. Epub 2013 Jul 16.
|
| 269 |
Detection of balanced translocations in acute lymphoblastic leukemia by a novel multiplex reverse transcriptase reverse transcription-polymerase chain reaction.J Cancer Res Ther. 2017 Oct-Dec;13(6):1042-1046. doi: 10.4103/0973-1482.172128.
|
| 270 |
Sister chromatid exchanges in leukemic patients.Cancer Genet Cytogenet. 1985 Feb 1;15(1-2):169-75. doi: 10.1016/0165-4608(85)90145-1.
|
| 271 |
Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.Am J Cancer Res. 2017 Jun 1;7(6):1389-1406. eCollection 2017.
|
| 272 |
The expression of IL-6 and its related genes in acute leukemia.Leuk Lymphoma. 1996 Mar;21(1-2):49-52. doi: 10.3109/10428199609067579.
|
| 273 |
MEIS1, PREP1, and PBX4 are differentially expressed in acute lymphoblastic leukemia: association of MEIS1 expression with higher proliferation and chemotherapy resistance.J Exp Clin Cancer Res. 2011 Dec 20;30(1):112. doi: 10.1186/1756-9966-30-112.
|
| 274 |
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids.Br J Haematol. 1990 Aug;75(4):489-95. doi: 10.1111/j.1365-2141.1990.tb07787.x.
|
| 275 |
Correlation of glucocorticoid-mediated E4BP4 upregulation with altered expression of pro- and anti-apoptotic genes in CEM human lymphoblastic leukemia cells.Biochem Biophys Res Commun. 2014 Aug 29;451(3):382-8. doi: 10.1016/j.bbrc.2014.07.103. Epub 2014 Aug 4.
|
| 276 |
Functional polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population.Eur J Haematol. 2011 Mar;86(3):199-205. doi: 10.1111/j.1600-0609.2010.01562.x. Epub 2011 Jan 25.
|
| 277 |
Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.Blood. 2004 Sep 15;104(6):1833-40. doi: 10.1182/blood-2003-10-3577. Epub 2004 Jun 8.
|
| 278 |
The nuclear migration gene NudC and human hematopoiesis.Leuk Lymphoma. 2000 Nov;39(5-6):447-54. doi: 10.3109/10428190009113375.
|
| 279 |
PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients.Pharmacogenomics J. 2020 Jun;20(3):415-425. doi: 10.1038/s41397-019-0130-0. Epub 2019 Dec 3.
|
| 280 |
cDNA cloning of human myeloperoxidase: decrease in myeloperoxidase mRNA upon induction of HL-60 cells.Proc Natl Acad Sci U S A. 1987 Apr;84(7):2057-61. doi: 10.1073/pnas.84.7.2057.
|
| 281 |
Expression of GATA transcription factors in myelogenous and lymphoblastic leukemia cells.Int J Hematol. 1997 Apr;65(3):239-49. doi: 10.1016/s0925-5710(96)00553-1.
|
| 282 |
RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.Int J Hematol. 2011 Sep;94(3):255-260. doi: 10.1007/s12185-011-0910-z. Epub 2011 Aug 24.
|
| 283 |
Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience.Oncology. 2019;97(2):59-74. doi: 10.1159/000500488. Epub 2019 Jul 1.
|
| 284 |
Matrix association region/scaffold attachment region: the crucial player in defining the positions of chromosome breaks mediated by bile acid-induced apoptosis in nasopharyngeal epithelial cells.BMC Med Genomics. 2019 Jan 15;12(1):9. doi: 10.1186/s12920-018-0465-4.
|
| 285 |
Analysis of HFE and TFR2 gene mutations in patients with acute leukemia.Leuk Res. 2005 Jun;29(6):661-4. doi: 10.1016/j.leukres.2005.01.001. Epub 2005 Feb 12.
|
| 286 |
The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer.Elife. 2015 Apr 28;4:e06377. doi: 10.7554/eLife.06377.
|
| 287 |
MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein.J Biomed Sci. 2002 May-Jun;9(3):234-45. doi: 10.1007/BF02256070.
|
| 288 |
Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia.Oncol Lett. 2017 Dec;14(6):8072-8077. doi: 10.3892/ol.2017.7229. Epub 2017 Oct 20.
|
| 289 |
The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.Haematologica. 2005 Apr;90(4):558-9.
|
| 290 |
IgH and TCRgamma gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias.Leuk Res. 2006 Feb;30(2):211-21. doi: 10.1016/j.leukres.2005.07.001. Epub 2005 Aug 15.
|
| 291 |
Examination of copy number variations of CHST9 in multiple types of hematologic malignancies.Cancer Genet Cytogenet. 2010 Dec;203(2):176-9. doi: 10.1016/j.cancergencyto.2010.07.132.
|
| 292 |
Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1.Blood. 1996 Apr 15;87(8):3368-74.
|
| 293 |
Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia.Leukemia. 2007 Dec;21(12):2470-5. doi: 10.1038/sj.leu.2404962. Epub 2007 Sep 27.
|
| 294 |
Expression of the DCC gene in human hematological malignancies.Leuk Lymphoma. 1994 Dec;16(1-2):13-8. doi: 10.3109/10428199409114135.
|
| 295 |
Compound Heterozygous DOCK8 Mutations in a Patient with B Lymphoblastic Leukemia and EBV-Associated Diffuse Large B Cell Lymphoma.J Clin Immunol. 2019 Aug;39(6):592-595. doi: 10.1007/s10875-019-00663-y. Epub 2019 Jul 2.
|
| 296 |
Electrochemical detection of leukemia oncogenes using enzyme-loaded carbon nanotube labels.Analyst. 2014 Sep 7;139(17):4223-30. doi: 10.1039/c3an01156a.
|
| 297 |
Growth factor independence 1 antagonizes a p53-induced DNA damage response pathway in lymphoblastic leukemia.Cancer Cell. 2013 Feb 11;23(2):200-14. doi: 10.1016/j.ccr.2013.01.011.
|
| 298 |
Identification of new markers discriminating between myeloid and lymphoid acute leukemia.Hematology. 2010 Aug;15(4):193-203. doi: 10.1179/102453310X12647083620769.
|
| 299 |
Shared roles for Scl and Lyl1 in murine platelet production and function.Blood. 2019 Sep 5;134(10):826-835. doi: 10.1182/blood.2019896175. Epub 2019 Jul 12.
|
| 300 |
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters.Cytometry B Clin Cytom. 2018 Mar;94(2):239-249. doi: 10.1002/cyto.b.21528. Epub 2017 May 5.
|
| 301 |
Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.BMC Cancer. 2019 Mar 6;19(1):202. doi: 10.1186/s12885-019-5411-0.
|
| 302 |
Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis.Cell J. 2017 Spring;19(Suppl 1):9-26. doi: 10.22074/cellj.2017.4908. Epub 2017 May 17.
|
| 303 |
Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes.BMC Cancer. 2015 Jul 23;15:539. doi: 10.1186/s12885-015-1549-6.
|
| 304 |
DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia.Leukemia. 2014 Apr;28(4):787-93. doi: 10.1038/leu.2013.270. Epub 2013 Sep 18.
|
| 305 |
Beclin-1 and hypoxia-inducible factor-1 genes expression: Potential biomarkers in acute leukemia patients.Cancer Biomark. 2016 Mar 18;16(4):619-26. doi: 10.3233/CBM-160603.
|
| 306 |
Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.Eur J Haematol. 2014 Mar;92(3):263-7. doi: 10.1111/ejh.12234. Epub 2013 Nov 28.
|
| 307 |
TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells.PLoS One. 2016 Mar 17;11(3):e0151341. doi: 10.1371/journal.pone.0151341. eCollection 2016.
|
| 308 |
Effect of Aplidin in acute lymphoblastic leukaemia cells.Br J Cancer. 2003 Aug 18;89(4):763-73. doi: 10.1038/sj.bjc.6601130.
|
| 309 |
Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia.Oncol Lett. 2018 Apr;15(4):5359-5367. doi: 10.3892/ol.2018.7985. Epub 2018 Feb 7.
|
| 310 |
Functional proteomics, human genetics and cancer biology of GIPC family members.Exp Mol Med. 2013 Jun 7;45(6):e26. doi: 10.1038/emm.2013.49.
|
| 311 |
AAV8 vector expressing IL24 efficiently suppresses tumor growth mediated by specific mechanisms in MLL/AF4-positive ALL model mice.Blood. 2012 Jan 5;119(1):64-71. doi: 10.1182/blood-2011-05-354050. Epub 2011 Oct 24.
|
| 312 |
The Genetic Variants of IKZF1 Gene Linked with the Growing Risk of Childhood Acute Lymphoblastic Leukaemia.Curr Mol Med. 2019;19(1):32-39. doi: 10.2174/1566524019666190219123900.
|
| 313 |
Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.Sao Paulo Med J. 2004 Jul 1;122(4):166-71. doi: 10.1590/s1516-31802004000400007. Epub 2004 Nov 9.
|
| 314 |
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia.Hum Gene Ther. 2018 May;29(5):602-613. doi: 10.1089/hum.2017.207. Epub 2018 Apr 16.
|
| 315 |
Prognostic impact of p15 gene aberrations in acute leukemia.Leuk Lymphoma. 2017 Feb;58(2):257-265. doi: 10.1080/10428194.2016.1201574. Epub 2016 Jul 12.
|
| 316 |
Identification of Risk Factors in High-Dose Methotrexate-Induced Acute Kidney Injury in Childhood Acute Lymphoblastic Leukemia.Chemotherapy. 2018 Apr 19;63(2):101-107. doi: 10.1159/000486823. Online ahead of print.
|
| 317 |
E2A-PBX1 Remodels Oncogenic Signaling Networks in B-cell Precursor Acute Lymphoid Leukemia.Cancer Res. 2016 Dec 1;76(23):6937-6949. doi: 10.1158/0008-5472.CAN-16-1899. Epub 2016 Oct 7.
|
| 318 |
Illegitimate RAG-mediated recombination events are involved in IKZF1 3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.Clin Exp Immunol. 2016 Sep;185(3):320-31. doi: 10.1111/cei.12812. Epub 2016 Jul 28.
|
| 319 |
Association Between the 5,10-MTHFR 677C>T and RFC1 80G>A Polymorphisms and Acute Lymphoblastic Leukemia.Arch Med Res. 2019 May;50(4):175-180. doi: 10.1016/j.arcmed.2019.07.010. Epub 2019 Sep 6.
|
| 320 |
Development of Escherichia coli Asparaginase II for Immunosensing: A Trade-Off between Receptor Density and Sensing Efficiency.ACS Omega. 2017 May 31;2(5):2114-2125. doi: 10.1021/acsomega.7b00110. Epub 2017 May 17.
|
| 321 |
ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.Hematology. 2017 Aug;22(7):386-391. doi: 10.1080/10245332.2017.1299417. Epub 2017 Mar 15.
|
| 322 |
Simultaneous involvement of 11q23 translocation resulting in chimeric MLL-AFF1 and a second translocation [t (9;21) (p13; p11.2)] in an infant acute lymphoblastic leukemia patient at relapse: A case report.Medicine (Baltimore). 2018 May;97(21):e10874. doi: 10.1097/MD.0000000000010874.
|
| 323 |
Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disability.Hum Mol Genet. 2011 May 15;20(10):1873-85. doi: 10.1093/hmg/ddr069. Epub 2011 Feb 17.
|
| 324 |
Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM.Anal Bioanal Chem. 2017 Apr;409(11):2767-2776. doi: 10.1007/s00216-017-0238-5. Epub 2017 Feb 22.
|
| 325 |
Two novel fusion genes, AIF1L-ETV6 and ABL1-AIF1L, result together with ETV6-ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin.Genes Chromosomes Cancer. 2018 Sep;57(9):471-477. doi: 10.1002/gcc.6. Epub 2018 Jul 30.
|
| 326 |
Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia?.Expert Opin Investig Drugs. 2005 Aug;14(8):1063-6. doi: 10.1517/13543784.14.8.1063.
|
| 327 |
APRIL is Involved in the Proliferation and Metastasis of Acute Lymphoblastic Leukemia Cells.J Pediatr Hematol Oncol. 2018 Nov;40(8):588-593. doi: 10.1097/MPH.0000000000001198.
|
| 328 |
Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.Mol Pharmacol. 2013 Jan;83(1):245-55. doi: 10.1124/mol.112.080788. Epub 2012 Oct 23.
|
| 329 |
Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.Mol Biol Rep. 2019 Feb;46(1):1295-1306. doi: 10.1007/s11033-019-04600-5. Epub 2019 Feb 2.
|
| 330 |
ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients.Haematologica. 2020 Apr;105(4):925-936. doi: 10.3324/haematol.2018.210286. Epub 2019 Aug 29.
|
| 331 |
Variants in ARID5B gene are associated with the development of acute lymphoblastic leukemia in Mexican children.Ann Hematol. 2019 Oct;98(10):2379-2388. doi: 10.1007/s00277-019-03730-x. Epub 2019 Jun 21.
|
| 332 |
Genomic hypomethylation in human chronic lymphocytic leukemia.Blood. 1992 Oct 15;80(8):2074-80.
|
| 333 |
ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children.Br J Haematol. 2014 Jun;165(6):836-41. doi: 10.1111/bjh.12834. Epub 2014 Mar 15.
|
| 334 |
Human Adipose Tissue Stem Cells Promote the Growth of Acute Lymphoblastic Leukemia Cells in NOD/SCID Mice.Stem Cell Rev Rep. 2018 Jun;14(3):451-460. doi: 10.1007/s12015-018-9806-0.
|
| 335 |
High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia.Blood. 2010 May 6;115(18):3737-44. doi: 10.1182/blood-2009-09-241943. Epub 2010 Jan 11.
|
| 336 |
Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in Tcell acute lymphoblastic leukemia.Asia Pac J Clin Oncol. 2018 Oct;14(5):e259-e265. doi: 10.1111/ajco.12979. Epub 2018 May 11.
|
| 337 |
Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: BIM Finally.Cancer Cell. 2018 Dec 10;34(6):869-871. doi: 10.1016/j.ccell.2018.11.011.
|
| 338 |
BIRC6/Apollon gene expression in childhood acute leukemia: impact on therapeutic response and prognosis.Eur J Haematol. 2012 Feb;88(2):118-27. doi: 10.1111/j.1600-0609.2011.01734.x. Epub 2012 Jan 4.
|
| 339 |
MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2010 Aug;49(8):682-7. doi: 10.1002/gcc.20776.
|
| 340 |
Germline Genetic Predisposition to Hematologic Malignancy.J Clin Oncol. 2017 Mar 20;35(9):1018-1028. doi: 10.1200/JCO.2016.70.8644. Epub 2017 Feb 13.
|
| 341 |
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia.J Biol Chem. 2016 Feb 26;291(9):4723-31. doi: 10.1074/jbc.M115.637835. Epub 2015 Dec 24.
|
| 342 |
Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter.Br J Haematol. 2006 Jul;134(2):137-44. doi: 10.1111/j.1365-2141.2006.06131.x.
|
| 343 |
Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia.Cancer Chemother Pharmacol. 2019 May;83(5):875-880. doi: 10.1007/s00280-019-03803-8. Epub 2019 Feb 26.
|
| 344 |
Investigation of NF-B-94ins/del ATTG and CARD8 (rs2043211) Gene Polymorphism in Acute Lymphoblastic Leukemia.Front Endocrinol (Lausanne). 2019 Aug 2;10:501. doi: 10.3389/fendo.2019.00501. eCollection 2019.
|
| 345 |
Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-B.Clin Cancer Res. 2013 Mar 15;19(6):1445-57. doi: 10.1158/1078-0432.CCR-12-1511. Epub 2013 Jan 28.
|
| 346 |
Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis.Cancer Res. 2000 Jun 1;60(11):2775-9.
|
| 347 |
Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways.Nucleic Acids Res. 2014 Jan;42(1):137-52. doi: 10.1093/nar/gkt855. Epub 2013 Sep 24.
|
| 348 |
Molecular cloning and chromosomal localization of the human cyclin C (CCNC) and cyclin E (CCNE) genes: deletion of the CCNC gene in human tumors.Genomics. 1996 Mar 1;32(2):253-9. doi: 10.1006/geno.1996.0112.
|
| 349 |
A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.PLoS One. 2012;7(9):e44654. doi: 10.1371/journal.pone.0044654. Epub 2012 Sep 25.
|
| 350 |
G19.4(alpha CD3) x B43(alpha CD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells.Blood. 1992 Dec 1;80(11):2826-34.
|
| 351 |
Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.Leukemia. 1996 Dec;10(12):1897-900.
|
| 352 |
Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukemias (ALLs) and in cell lines of B-cell origin.Leukemia. 1994 Dec;8(12):2127-33.
|
| 353 |
Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.Blood. 2019 Oct 10;134(15):1227-1237. doi: 10.1182/blood.2018890764.
|
| 354 |
Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment.Genes (Basel). 2019 Mar 1;10(3):191. doi: 10.3390/genes10030191.
|
| 355 |
Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia.Cell Death Dis. 2018 Sep 11;9(9):925. doi: 10.1038/s41419-018-0964-4.
|
| 356 |
Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia.Blood. 2009 Feb 26;113(9):1892-8. doi: 10.1182/blood-2008-02-141002. Epub 2008 Dec 23.
|
| 357 |
The spectrum of acute lymphoblastic leukemia with mature B-cell phenotype.Leuk Res. 2003 Mar;27(3):231-4. doi: 10.1016/s0145-2126(02)00129-7.
|
| 358 |
Oligomeric interface modulation causes misregulation of purine 5-nucleotidase in relapsed leukemia.BMC Biol. 2016 Oct 19;14(1):91. doi: 10.1186/s12915-016-0313-y.
|
| 359 |
Pak1 gene functioned differentially in different BCR-ABL subtypes in leukemiagenesis and treatment response through STAT5 pathway.Leuk Res. 2019 Apr;79:6-16. doi: 10.1016/j.leukres.2019.01.012. Epub 2019 Jan 24.
|
| 360 |
The prognostic potential of coilin in association with p27 expression in pediatric acute lymphoblastic leukemia for disease relapse.Cancer Cell Int. 2018 Jul 27;18:106. doi: 10.1186/s12935-018-0600-5. eCollection 2018.
|
| 361 |
Monosomy 20 as a pointer to dicentric (9;20) in acute lymphoblastic leukemia.Leukemia. 2000 Feb;14(2):241-6. doi: 10.1038/sj.leu.2401654.
|
| 362 |
Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia.Blood. 1994 Sep 15;84(6):1731-6.
|
| 363 |
Cyfip1 is downregulated in acute lymphoblastic leukemia and may be a potential biomarker in acute lymphoblastic leukemia.Tumour Biol. 2016 Jul;37(7):9285-8. doi: 10.1007/s13277-016-4786-7. Epub 2016 Jan 15.
|
| 364 |
Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia.Blood. 2007 Apr 15;109(8):3462-9. doi: 10.1182/blood-2006-09-047043. Epub 2006 Dec 5.
|
| 365 |
Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias.J Clin Pathol. 2008 Jul;61(7):844-7. doi: 10.1136/jcp.2007.047324.
|
| 366 |
Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia. Cancer Res. 2007 Mar 15;67(6):2617-25.
|
| 367 |
Association between DEFB1 gene haplotype and herpes viruses seroprevalence in children with acute lymphoblastic leukemia.Pediatr Hematol Oncol. 2009 Nov;26(8):573-82. doi: 10.3109/08880010903271705.
|
| 368 |
ETS1 and SP1 drive DHX15 expression in acute lymphoblastic leukaemia.J Cell Mol Med. 2018 May;22(5):2612-2621. doi: 10.1111/jcmm.13525. Epub 2018 Mar 7.
|
| 369 |
T-cell acute lymphoblastic leukemia with natural killer cell phenotype.Am J Hematol. 1986 Aug;22(4):355-64. doi: 10.1002/ajh.2830220404.
|
| 370 |
Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation.Oncol Rep. 2007 Aug;18(2):417-23.
|
| 371 |
Expression of terminal deoxynucleotidyltransferase gene in a case of adult T-cell leukemia.Int J Hematol. 1991 Feb;54(1):37-40.
|
| 372 |
Dual-specificity phosphatase Pyst2-L is constitutively highly expressed in myeloid leukemia and other malignant cells.Oncogene. 2003 Oct 23;22(48):7649-60. doi: 10.1038/sj.onc.1206971.
|
| 373 |
CD22 Exon 12 deletion is a characteristic genetic defect of therapy-refractory clones in paediatric acute lymphoblastic leukaemia.Br J Haematol. 2012 Jan;156(1):89-98. doi: 10.1111/j.1365-2141.2011.08901.x. Epub 2011 Oct 21.
|
| 374 |
Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy.PLoS One. 2015 Oct 14;10(10):e0140564. doi: 10.1371/journal.pone.0140564. eCollection 2015.
|
| 375 |
ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.Cell Physiol Biochem. 2018;46(4):1525-1535. doi: 10.1159/000489196. Epub 2018 Apr 19.
|
| 376 |
Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.Acta Haematol. 2013;129(2):121-5. doi: 10.1159/000342897. Epub 2012 Nov 28.
|
| 377 |
Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.Oncotarget. 2017 Aug 4;8(40):68208-68220. doi: 10.18632/oncotarget.19919. eCollection 2017 Sep 15.
|
| 378 |
Current status of diagnosis and prognosis of infant acute leukemia in China.Pediatr Blood Cancer. 2009 Dec;53(6):973-7. doi: 10.1002/pbc.22145.
|
| 379 |
Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.Cell Oncol. 2008;30(4):299-306. doi: 10.3233/clo-2008-0426.
|
| 380 |
PI3K- inhibition using CAL-101 exerts apoptotic effects and increases doxorubicin-induced cell death in pre-B-acute lymphoblastic leukemia cells.Anticancer Drugs. 2017 Apr;28(4):436-445. doi: 10.1097/CAD.0000000000000477.
|
| 381 |
Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells.J Extracell Vesicles. 2019 Mar 12;8(1):1588538. doi: 10.1080/20013078.2019.1588538. eCollection 2019.
|
| 382 |
F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation.Blood. 2012 Mar 29;119(13):3132-41. doi: 10.1182/blood-2011-06-358911. Epub 2012 Feb 8.
|
| 383 |
Identification of promising prognostic genes for relapsed acute lymphoblastic leukemia.Blood Cells Mol Dis. 2019 Jul;77:113-119. doi: 10.1016/j.bcmd.2019.04.010. Epub 2019 Apr 18.
|
| 384 |
Low representation of Fc receptor-like 1-5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia.Cancer Immunol Immunother. 2009 Jun;58(6):989-96. doi: 10.1007/s00262-008-0589-z. Epub 2008 Sep 19.
|
| 385 |
Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma.PLoS One. 2013 May 7;8(5):e62346. doi: 10.1371/journal.pone.0062346. Print 2013.
|
| 386 |
MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2.J Gene Med. 2017 Jun;19(6-7). doi: 10.1002/jgm.2898.
|
| 387 |
FOXO3 gene polymorphisms influence the risk of acute lymphoblastic leukemia in Chinese children.J Cell Biochem. 2020 Feb;121(2):2019-2026. doi: 10.1002/jcb.29436. Epub 2019 Nov 6.
|
| 388 |
Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.Br J Haematol. 2011 Jun;153(6):741-52. doi: 10.1111/j.1365-2141.2011.08671.x. Epub 2011 Apr 25.
|
| 389 |
Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.Br J Haematol. 2007 Jan;136(2):212-9. doi: 10.1111/j.1365-2141.2006.06407.x. Epub 2006 Dec 8.
|
| 390 |
G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.Blood. 1995 Apr 1;85(7):1836-42.
|
| 391 |
Novel insights into etiologies of leukemia: a HuGE review and meta-analysis of CYP1A1 polymorphisms and leukemia risk.Am J Epidemiol. 2013 Aug 15;178(4):493-507. doi: 10.1093/aje/kwt016. Epub 2013 May 24.
|
| 392 |
Mu class glutathione S-transferase mRNA isoform expression in acute lymphoblastic leukaemia.Br J Haematol. 2003 Jan;120(1):80-8. doi: 10.1046/j.1365-2141.2003.04039.x.
|
| 393 |
Glycophorin A mutations and risk of secondary leukaemia in patients treated for childhood acute lymphoblastic leukaemia.Br J Haematol. 1996 Apr;93(1):117-24. doi: 10.1046/j.1365-2141.1996.4621001.x.
|
| 394 |
Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.J Hum Genet. 2007;52(4):328-333. doi: 10.1007/s10038-007-0119-4. Epub 2007 Feb 20.
|
| 395 |
Significance of CASP8AP2 and H2AFZ expression in survival and risk of relapse in children with acute lymphoblastic leukemia.Leuk Lymphoma. 2014 Oct;55(10):2305-11. doi: 10.3109/10428194.2013.878458. Epub 2014 Feb 24.
|
| 396 |
Motor skill delays in pre-school children with leukemia one year after treatment: Hematopoietic stem cell transplantation therapy as an important risk factor.PLoS One. 2017 Oct 24;12(10):e0186787. doi: 10.1371/journal.pone.0186787. eCollection 2017.
|
| 397 |
Transmission of HLA-DP variants from parents to children with B-cell precursor acute lymphoblastic leukemia: log-linear analysis using the case-parent design.Hum Immunol. 2011 Oct;72(10):897-903. doi: 10.1016/j.humimm.2011.05.011. Epub 2011 May 24.
|
| 398 |
High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.Leukemia. 1993 Mar;7(3):446-51.
|
| 399 |
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo.Blood. 2012 Apr 12;119(15):3440-9. doi: 10.1182/blood-2011-06-357939. Epub 2012 Feb 27.
|
| 400 |
Expression of selected human HOX-2 genes in B/T acute lymphoid leukemia and interleukin-2/interleukin-1 beta-stimulated natural killer lymphocytes.Blood. 1992 Jul 1;80(1):185-93.
|
| 401 |
Mutation analysis of the HOX paralogous 4-13 genes in children with acute lymphoid malignancies: identification of a novel germline mutation of HOXD4 leading to a partial loss-of-function.Hum Mutat. 2005 Apr;25(4):384-95. doi: 10.1002/humu.20155.
|
| 402 |
Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.J Natl Cancer Inst. 2008 Apr 16;100(8):580-95. doi: 10.1093/jnci/djn076. Epub 2008 Apr 8.
|
| 403 |
Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia.Leukemia. 2000 Jan;14(1):22-7. doi: 10.1038/sj.leu.2401641.
|
| 404 |
Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.Blood Cells Mol Dis. 2011 Apr 15;46(4):321-6. doi: 10.1016/j.bcmd.2011.02.005. Epub 2011 Mar 17.
|
| 405 |
Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case-Control and Family-Based Studies in Multiethnic Populations.Cancer Epidemiol Biomarkers Prev. 2017 Oct;26(10):1531-1539. doi: 10.1158/1055-9965.EPI-17-0360. Epub 2017 Jul 27.
|
| 406 |
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors.PLoS One. 2016 Aug 22;11(8):e0159477. doi: 10.1371/journal.pone.0159477. eCollection 2016.
|
| 407 |
The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.Cancer Med. 2019 May;8(5):2095-2103. doi: 10.1002/cam4.2096. Epub 2019 Mar 26.
|
| 408 |
miR-153-3p Suppresses Inhibitor of Growth Protein 2 Expression to Function as Tumor Suppressor in Acute Lymphoblastic Leukemia.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819852990. doi: 10.1177/1533033819852990.
|
| 409 |
Effect of IRS4 levels on PI 3-kinase signalling.PLoS One. 2013 Sep 10;8(9):e73327. doi: 10.1371/journal.pone.0073327. eCollection 2013.
|
| 410 |
GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.Leukemia. 2013 Mar;27(3):578-85. doi: 10.1038/leu.2012.265. Epub 2012 Sep 11.
|
| 411 |
KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in leukemia.Mol Cell Biol. 2012 Jul;32(14):2917-33. doi: 10.1128/MCB.00133-12. Epub 2012 May 21.
|
| 412 |
Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.J Pediatr Hematol Oncol. 2019 Nov;41(8):653-656. doi: 10.1097/MPH.0000000000001249.
|
| 413 |
Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report.Leukemia. 2014 Jun;28(6):1235-41. doi: 10.1038/leu.2013.367. Epub 2013 Dec 4.
|
| 414 |
Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14).Oncogene. 2003 Mar 6;22(9):1418-24. doi: 10.1038/sj.onc.1206272.
|
| 415 |
Adaptor molecules expression in normal lymphopoiesis and in childhood leukemia.Immunol Lett. 2009 Feb 21;122(2):185-92. doi: 10.1016/j.imlet.2008.12.008. Epub 2009 Feb 11.
|
| 416 |
Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells.Oncotarget. 2018 Feb 5;9(16):12842-12852. doi: 10.18632/oncotarget.24401. eCollection 2018 Feb 27.
|
| 417 |
Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.Genes Chromosomes Cancer. 2003 Nov;38(3):269-73. doi: 10.1002/gcc.10283.
|
| 418 |
Inv(11)(q21q23); KMT2A-MAML2, a Recurrent Genetic Abnormality in T-Cell Therapy-related Acute Lymphoblastic Leukemia.J Pediatr Hematol Oncol. 2020 May;42(4):e258-e261. doi: 10.1097/MPH.0000000000001572.
|
| 419 |
MLL is fused to EB1 (MAPRE1), which encodes a microtubule-associated protein, in a patient with acute lymphoblastic leukemia.Genes Chromosomes Cancer. 2005 Jun;43(2):206-10. doi: 10.1002/gcc.20174.
|
| 420 |
Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patient.Int J Hematol. 2012 Dec;96(6):806-9. doi: 10.1007/s12185-012-1185-8. Epub 2012 Oct 9.
|
| 421 |
BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?.PLoS One. 2015 Jul 14;10(7):e0132926. doi: 10.1371/journal.pone.0132926. eCollection 2015.
|
| 422 |
Chromosomal translocation-mediated evasion from miRNA induces strong MEF2D fusion protein expression, causing inhibition of PAX5 transcriptional activity.Oncogene. 2019 Mar;38(13):2263-2274. doi: 10.1038/s41388-018-0573-9. Epub 2018 Nov 26.
|
| 423 |
The study of METTL3 and METTL14 expressions in childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.Mol Genet Genomic Med. 2019 Oct;7(10):e00933. doi: 10.1002/mgg3.933. Epub 2019 Aug 20.
|
| 424 |
Bone marrow transplantation for acute leukemia using a histocompatible paternal donor.Acta Haematol. 1979;61(2):80-4. doi: 10.1159/000207636.
|
| 425 |
Successful Treatment of a Very Late Isolated Relapse in an Adolescent With a PICALM-MLLT10 Positive T-lineage Acute Lymphoblastic Leukemia.J Pediatr Hematol Oncol. 2018 Apr;40(3):e191-e194. doi: 10.1097/MPH.0000000000000996.
|
| 426 |
Bile acids at neutral and acidic pH induce apoptosis and gene cleavages in nasopharyngeal epithelial cells: implications in chromosome rearrangement.BMC Cancer. 2018 Apr 12;18(1):409. doi: 10.1186/s12885-018-4327-4.
|
| 427 |
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies.Blood. 1985 Mar;65(3):730-5.
|
| 428 |
Isodicentric Philadelphia chromosome in acute lymphoblastic leukemia with der(7;12)(q10;q10).Leuk Res. 2007 May;31(5):713-8. doi: 10.1016/j.leukres.2006.05.023. Epub 2006 Sep 18.
|
| 429 |
The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.Int J Cancer. 1989 Jun 15;43(6):1034-6. doi: 10.1002/ijc.2910430613.
|
| 430 |
Intracytoplasmic detection of the Tac (p55) chain of interleukin-2 receptor in pre-B leukemic cells associated with a constitutive expression of Tac mRNA.Leukemia. 1990 Dec;4(12):819-25.
|
| 431 |
A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis.Cell Death Differ. 2017 Jan;24(1):83-97. doi: 10.1038/cdd.2016.102. Epub 2016 Nov 11.
|
| 432 |
Association of methylenetetrahydrofolate dehydrogenase 1 polymorphisms with cancer: a meta-analysis.PLoS One. 2013 Jul 19;8(7):e69366. doi: 10.1371/journal.pone.0069366. Print 2013.
|
| 433 |
Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.Br J Haematol. 2014 Nov;167(4):487-99. doi: 10.1111/bjh.13066. Epub 2014 Sep 8.
|
| 434 |
NBN and XRCC3 genetic variants in childhood acute lymphoblastic leukaemia.Cancer Epidemiol. 2014 Oct;38(5):563-8. doi: 10.1016/j.canep.2014.08.002. Epub 2014 Aug 27.
|
| 435 |
CREBBP mutations in relapsed acute lymphoblastic leukaemia.Nature. 2011 Mar 10;471(7337):235-9. doi: 10.1038/nature09727.
|
| 436 |
NET1 Enhances Proliferation and Chemoresistance in Acute Lymphoblastic Leukemia Cells.Oncol Res. 2019 Aug 8;27(8):935-944. doi: 10.3727/096504019X15555388198071. Epub 2019 Apr 17.
|
| 437 |
Down regulation of membrane-bound Neu3 constitutes a new potential marker for childhood acute lymphoblastic leukemia and induces apoptosis suppression of neoplastic cells.Int J Cancer. 2010 Jan 15;126(2):337-49. doi: 10.1002/ijc.24733.
|
| 438 |
Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2;19;11) (p12;p13.3;q23).Cancer Genet Cytogenet. 2010 Feb;197(1):32-8. doi: 10.1016/j.cancergencyto.2009.10.009.
|
| 439 |
An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.Oncogene. 2019 Jan;38(5):671-686. doi: 10.1038/s41388-018-0474-y. Epub 2018 Aug 31.
|
| 440 |
The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.J Pediatr. 2020 Jan;216:150-157.e1. doi: 10.1016/j.jpeds.2019.09.024. Epub 2019 Oct 18.
|
| 441 |
NUP214 in Leukemia: It's More than Transport.Cells. 2019 Jan 21;8(1):76. doi: 10.3390/cells8010076.
|
| 442 |
The nuclear pore proteins Nup88/214 and T-cell acute lymphatic leukemia-associated NUP214 fusion proteins regulate Notch signaling.J Biol Chem. 2019 Aug 2;294(31):11741-11750. doi: 10.1074/jbc.RA118.006357. Epub 2019 Jun 11.
|
| 443 |
Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia.Int J Cancer. 2006 Apr 15;118(8):1945-53. doi: 10.1002/ijc.21584.
|
| 444 |
Alterations of deadenylase expression in acute leukemias: evidence for poly(a)-specific ribonuclease as a potential biomarker.Acta Haematol. 2012;128(1):39-46. doi: 10.1159/000337418. Epub 2012 May 17.
|
| 445 |
Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.Genes Chromosomes Cancer. 2011 Dec;50(12):1043-53. doi: 10.1002/gcc.20922. Epub 2011 Aug 24.
|
| 446 |
Aberrant methylation of protocadherin 17 and its prognostic value in pediatric acute lymphoblastic leukemia.Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26259. Epub 2016 Sep 19.
|
| 447 |
Up-regulation of PER3 Expression Is Correlated with Better Clinical Outcome in Acute Leukemia.Anticancer Res. 2015 Dec;35(12):6615-22.
|
| 448 |
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.Br J Haematol. 2003 Jun;121(5):730-8. doi: 10.1046/j.1365-2141.2003.04343.x.
|
| 449 |
Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage.Exp Hematol. 2001 Jan;29(1):93-103. doi: 10.1016/s0301-472x(00)00620-2.
|
| 450 |
Deletion of the Miz-1 POZ Domain Increases Efficacy of Cytarabine Treatment in T- and B-ALL/Lymphoma Mouse Models.Cancer Res. 2019 Aug 15;79(16):4184-4195. doi: 10.1158/0008-5472.CAN-18-3038. Epub 2019 Jul 4.
|
| 451 |
Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility.Medicine (Baltimore). 2016 May;95(18):e3542. doi: 10.1097/MD.0000000000003542.
|
| 452 |
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.Leukemia. 2015 Nov;29(11):2154-61. doi: 10.1038/leu.2015.134. Epub 2015 Jun 8.
|
| 453 |
RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance.Blood. 2008 Apr 1;111(7):3735-41. doi: 10.1182/blood-2007-07-102533. Epub 2008 Jan 17.
|
| 454 |
Mutations of perforin gene in Chinese patients with acute lymphoblastic leukemia.Leuk Res. 2011 Feb;35(2):196-9. doi: 10.1016/j.leukres.2010.06.016. Epub 2010 Jul 16.
|
| 455 |
The ARTS connection: role of ARTS in apoptosis and cancer.Cell Cycle. 2004 Aug;3(8):1021-3. Epub 2004 Aug 16.
|
| 456 |
MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.Leuk Res. 2014 Nov;38(11):1316-9. doi: 10.1016/j.leukres.2014.08.011. Epub 2014 Aug 29.
|
| 457 |
Polyclonal hemopoiesis in leukemia patients following molecularly documented remission.Leukemia. 1994 Apr;8 Suppl 1:S137-9.
|
| 458 |
Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11).Leukemia. 2002 Nov;16(11):2205-12. doi: 10.1038/sj.leu.2402671.
|
| 459 |
t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia.Br J Haematol. 2000 Jun;109(4):788-93. doi: 10.1046/j.1365-2141.2000.02106.x.
|
| 460 |
Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.Sci Signal. 2013 Mar 26;6(268):ra21. doi: 10.1126/scisignal.2003848.
|
| 461 |
Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia.Ann Hematol. 2019 Dec;98(12):2719-2727. doi: 10.1007/s00277-019-03775-y. Epub 2019 Sep 5.
|
| 462 |
The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.Leukemia. 2018 Feb;32(2):323-331. doi: 10.1038/leu.2017.216. Epub 2017 Jul 10.
|
| 463 |
Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.Blood. 2012 Nov 1;120(18):3764-73. doi: 10.1182/blood-2012-03-415349. Epub 2012 Sep 13.
|
| 464 |
Persistent detection of a novel MLL-SACM1L rearrangement in the absence of leukemia.Leuk Res. 2010 Oct;34(10):1398-401. doi: 10.1016/j.leukres.2010.05.001.
|
| 465 |
Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2.Genomics. 1992 Jun;13(2):287-92. doi: 10.1016/0888-7543(92)90244-m.
|
| 466 |
A translocation in acute lymphoblastic leukemia that cytogenetically mimics the recurrent MLL-AFF1 translocation and fuses SEPT11 to MLL.Cancer Genet Cytogenet. 2010 Aug;201(1):48-51. doi: 10.1016/j.cancergencyto.2010.05.002.
|
| 467 |
The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines.Genes Chromosomes Cancer. 2001 Mar;30(3):230-5. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1084>3.0.co;2-j.
|
| 468 |
Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL. Pharmacogenomics. 2012 Jul;13(9):1001-8.
|
| 469 |
Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.Hum Mol Genet. 2014 Feb 1;23(3):590-601. doi: 10.1093/hmg/ddt447. Epub 2013 Sep 17.
|
| 470 |
Regulatory network of GATA3 in pediatric acute lymphoblastic leukemia.Oncotarget. 2017 May 30;8(22):36040-36053. doi: 10.18632/oncotarget.16424.
|
| 471 |
Identification of SPAG9 as a novel JAK2 fusion partner gene in pediatric acute lymphoblastic leukemia with t(9;17)(p24;q21).Genes Chromosomes Cancer. 2015 Jul;54(7):401-8. doi: 10.1002/gcc.22251. Epub 2015 May 7.
|
| 472 |
Instability at the FRA8I common fragile site disrupts the genomic integrity of the KIAA0146, CEBPD and PRKDC genes in colorectal cancer.Cancer Lett. 2013 Aug 9;336(1):85-95. doi: 10.1016/j.canlet.2013.04.007. Epub 2013 Apr 16.
|
| 473 |
Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.Int J Cancer. 2013 Jul;133(1):260-5. doi: 10.1002/ijc.28011. Epub 2013 Feb 5.
|
| 474 |
Novel SSBP2-JAK2 fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia.Genes Chromosomes Cancer. 2008 Oct;47(10):884-9. doi: 10.1002/gcc.20585.
|
| 475 |
High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia.Sci Rep. 2018 Jan 12;8(1):693. doi: 10.1038/s41598-017-17704-4.
|
| 476 |
Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia.J Med Biochem. 2018 Apr 1;37(2):128-133. doi: 10.1515/jomb-2017-0042. eCollection 2018 Apr.
|
| 477 |
Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12).Cancer Genet. 2011 Mar;204(3):147-52. doi: 10.1016/j.cancergen.2011.01.003.
|
| 478 |
Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells.Blood. 2001 Oct 15;98(8):2456-65. doi: 10.1182/blood.v98.8.2456.
|
| 479 |
Investigation of copy-number variations of C8orf4 in hematological malignancies.Med Oncol. 2011 Dec;28 Suppl 1:S647-52. doi: 10.1007/s12032-010-9698-6. Epub 2010 Sep 29.
|
| 480 |
Rearrangements of the T cell receptor delta gene in T acute lymphoblastic leukemia cells are distinct from those occurring in B lineage acute lymphoblastic leukemia and preferentially involve one V delta gene segment.J Immunol. 1989 May 1;142(9):3305-11.
|
| 481 |
TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia.Leuk Res. 2018 Nov;74:42-46. doi: 10.1016/j.leukres.2018.09.010. Epub 2018 Sep 26.
|
| 482 |
Simultaneous translocation of both TCR Loci (14q11) with rare partner loci (Xq22 and 12p13) in a case of T-lymphoblastic leukemia.Ann Lab Med. 2012 May;32(3):220-4. doi: 10.3343/alm.2012.32.3.220. Epub 2012 Apr 18.
|
| 483 |
Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.BMC Cancer. 2019 Feb 27;19(1):179. doi: 10.1186/s12885-019-5377-y.
|
| 484 |
Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.Leukemia. 1994 Dec;8(12):2083-94.
|
| 485 |
Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells.J Extracell Vesicles. 2017 Feb 28;6(1):1294368. doi: 10.1080/20013078.2017.1294368. eCollection 2017.
|
| 486 |
LIM domain proteins in leukaemia and development.Semin Cancer Biol. 1993 Dec;4(6):349-58.
|
| 487 |
Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL).Leuk Res. 2006 Jul;30(7):883-9. doi: 10.1016/j.leukres.2005.11.012. Epub 2006 Jan 6.
|
| 488 |
Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study.Cancer. 2018 Dec 1;124(23):4538-4547. doi: 10.1002/cncr.31758. Epub 2018 Oct 10.
|
| 489 |
Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.Oncogene. 2013 May 16;32(20):2586-91. doi: 10.1038/onc.2012.263. Epub 2012 Jul 2.
|
| 490 |
CD99 expression is strongly associated with clinical outcome in children with B-cell precursor acute lymphoblastic leukaemia.Br J Haematol. 2019 Feb;184(3):418-423. doi: 10.1111/bjh.15683. Epub 2018 Nov 28.
|
| 491 |
Characterization of a novel acquired der(1)del(1)(p13p31)t(1;15)(q42;q15) in a high risk t(12;21)-positive acute lymphoblastic leukemia.Gene. 2016 Dec 20;595(1):39-48. doi: 10.1016/j.gene.2016.09.030. Epub 2016 Sep 21.
|
| 492 |
EXT1, Regulated by MiR-665, Promotes Cell Apoptosis via ERK1/2 Signaling Pathway in Acute Lymphoblastic Leukemia.Med Sci Monit. 2019 Aug 29;25:6491-6503. doi: 10.12659/MSM.918295.
|
| 493 |
Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.Leuk Res. 2018 Dec;75:36-44. doi: 10.1016/j.leukres.2018.11.001. Epub 2018 Nov 3.
|
| 494 |
A unique phenotype of T-cell acute lymphoblastic leukemia in a patient with GATA2 haploinsufficiency.Pediatr Blood Cancer. 2019 Jun;66(6):e27649. doi: 10.1002/pbc.27649. Epub 2019 Feb 25.
|
| 495 |
Decreased expression of the augmenter of liver regeneration results in growth inhibition and increased chemosensitivity of acute T lymphoblastic leukemia cells.Oncol Rep. 2017 Nov;38(5):3130-3136. doi: 10.3892/or.2017.5984. Epub 2017 Sep 21.
|
| 496 |
A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.Cancer Res. 2018 Mar 15;78(6):1549-1560. doi: 10.1158/0008-5472.CAN-17-2106. Epub 2018 Jan 17.
|
| 497 |
HAP1 loss confers l-asparaginase resistance in ALL by downregulating the calpain-1-Bid-caspase-3/12 pathway.Blood. 2019 May 16;133(20):2222-2232. doi: 10.1182/blood-2018-12-890236. Epub 2019 Feb 28.
|
| 498 |
Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.Autoimmunity. 2010 Dec;43(8):690-7. doi: 10.3109/08916930903567492.
|
| 499 |
Inhibition of HOXB7 suppresses p27-mediated acute lymphoblastic leukemia by regulating basic fibroblast growth factor and ERK1/2.Life Sci. 2019 Feb 1;218:1-7. doi: 10.1016/j.lfs.2018.12.011. Epub 2018 Dec 8.
|
| 500 |
Plant homeodomain finger protein 2 as a novel IKAROS target in acute lymphoblastic leukemia.Epigenomics. 2018 Jan;10(1):59-69. doi: 10.2217/epi-2017-0092. Epub 2017 Oct 10.
|
| 501 |
Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study.Biol Blood Marrow Transplant. 2016 Mar;22(3):423-31. doi: 10.1016/j.bbmt.2015.09.029. Epub 2015 Oct 9.
|
| 502 |
The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia.Leuk Res. 2016 Mar;42:28-36. doi: 10.1016/j.leukres.2016.01.013. Epub 2016 Jan 28.
|
| 503 |
Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.Clin Chim Acta. 2012 Oct 9;413(19-20):1542-8. doi: 10.1016/j.cca.2012.06.025. Epub 2012 Jun 29.
|
| 504 |
Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia.PLoS One. 2017 Mar 9;12(3):e0173472. doi: 10.1371/journal.pone.0173472. eCollection 2017.
|
| 505 |
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.Haematologica. 2016 Aug;101(8):951-8. doi: 10.3324/haematol.2016.143875. Epub 2016 May 5.
|
|
|
|
|
|
|
